Zobrazeno 1 - 10
of 32
pro vyhledávání: '"BIEREND, A."'
Autor:
Karl R. Kleinknecht, Mira Bierend, Lisa-Maria Keim, Frederik Bartels, Amit Lampit, Carsten Finke
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-10 (2024)
Abstract Cancer-related cognitive impairment has a significant impact on the quality of life and perceived cognitive ability of breast cancer patients and frequently affects attention, working memory, and executive function. Several interventional ap
Externí odkaz:
https://doaj.org/article/1b40d0b1dbc548c49c93a67b3cb39b81
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bierend, Doug (AUTHOR)
Publikováno v:
Earth Island Journal. Winter2023, Vol. 37 Issue 4, p48-55. 6p. 5 Color Photographs.
Publikováno v:
In Journal of Thrombosis and Haemostasis December 2010 8(12):2662-2670
Publikováno v:
International Journal of Pharmaceutics. 422:75-82
Dry powder formulations are often composed of fine drug particles and coarser carrier particles, typically alpha-lactose monohydrate. However, the performance of a powder formulation may be highly dependent on the lactose quality and source. This stu
Autor:
D. Tsikas, R. Trinks, Rainer H. Böger, Ghainsom D. Kom, Edzard Schwedhelm, A. Bierend, Renke Maas
Publikováno v:
Journal of Thrombosis and Haemostasis. 8:2662-2670
Summary. Aim: Insufficient platelet inhibition by low-dose aspirin is associated with poor prognosis in patients with coronary heart disease (CHD). We sought to investigate the prevalence of this phenomenon in patients with stable CHD and to study wh
Autor:
Anneke Bierend, Edzard Schwedhelm, Rainer H. Böger, Tanja K. Rudolph, Ralf A. Benndorf, Renke Maas, Gerhild I. Böger, Ekaterina Dumbadze
Publikováno v:
Journal of the American College of Cardiology. 49(23):2274-2282
Objectives We hypothesized that the level of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of endothelial nitric oxide (NO) synthase (eNOS), might determine the endothelial effects of statins. Background Endothelial NO synthase is up-re
Publikováno v:
British journal of clinical pharmacology. 65(4)
What is already known about this subject • Genetic polymorphisms of the P2Y12 ADP receptor on platelets have been shown to contribute to variability in platelet aggregation in healthy humans. • P2Y12 ADP receptor polymorphisms are more frequently
Autor:
Gerhild I, Böger, Tanja K, Rudolph, Renke, Maas, Edzard, Schwedhelm, Ekaterina, Dumbadze, Anneke, Bierend, Ralf A, Benndorf, Rainer H, Böger
Publikováno v:
Journal of the American College of Cardiology. 49(23)
We hypothesized that the level of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of endothelial nitric oxide (NO) synthase (eNOS), might determine the endothelial effects of statins.Endothelial NO synthase is up-regulated by statins. How
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.